Alzheimer's Drug Discovery Foundation: Diagnostics Accelerator- Peripheral Biomarkers Program (LOI)

The purpose is to provide newly independent investigators with funding that will allow them to develop preliminary or pilot data, to test procedures and to develop hypotheses. The grants are for  investigators who are less than 10 years past their doctoral or post residency (MD or DO) or investigators that are new to Alzheimer’s and related dementia field of research even if past the 10yrs

Funding Priorities:

Modalities: Blood and other peripheral markers, including saliva, urine, and ocular biomarkers are encouraged.

Biomarker targets: Neuroprotection, Neurodegeneration, Protein misfolding, Synaptic integrity and/or activity, vascular injury and blood-brain barrier integrity, Mitochondria and metabolic function, Oxidative stress, White matter changes.

https://goo.gl/sWPp6o